ALIGN TECHNOLOGY, INC. Payments to Acquire Available-for-sale Securities
ALIGN TECHNOLOGY, INC. (ALGN) reported Payments to Acquire Available-for-sale Securities of $5.34 million for the 6-month period ending 2020-06-30, per its 10-Q filed 2020-07-31.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireAvailableForSaleSecurities · last filed 2020-07-31
- ALIGN TECHNOLOGY, INC. payments to acquire available-for-sale securities for the quarter ending 2020-06-30 was $0.00, a 100.00% decline year-over-year.
- ALIGN TECHNOLOGY, INC. payments to acquire available-for-sale securities for the quarter ending 2020-03-31 was $5.34M, a 95.76% decline year-over-year.
- ALIGN TECHNOLOGY, INC. payments to acquire available-for-sale securities for the quarter ending 2019-12-31 was $104.48M, a 246.31% increase year-over-year.
- ALIGN TECHNOLOGY, INC. payments to acquire available-for-sale securities for the quarter ending 2019-09-30 was $234.81M, a 227.87% increase year-over-year.
- ALIGN TECHNOLOGY, INC. payments to acquire available-for-sale securities for fiscal 2019 was $693.28M, a 284.75% increase from fiscal 2018.
- ALIGN TECHNOLOGY, INC. payments to acquire available-for-sale securities for fiscal 2018 was $180.19M, a 53.83% decline from fiscal 2017.
- ALIGN TECHNOLOGY, INC. payments to acquire available-for-sale securities for fiscal 2017 was $390.24M, a 3.79% decline from fiscal 2016.
- ALIGN TECHNOLOGY, INC. payments to acquire available-for-sale securities for fiscal 2016 was $405.61M, a 9.28% decline from fiscal 2015.
| Period end | Payments to Acquire Available-for-sale Securities 3 month | Payments to Acquire Available-for-sale Securities 6 month | Payments to Acquire Available-for-sale Securities 9 month | Payments to Acquire Available-for-sale Securities 12 month |
|---|---|---|---|---|
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-31 | $5.34M 10-Q · filed 2020-07-31 | $109.82M derived: sum of 3 quarters · filed 2020-07-31 | $344.63M derived: sum of 4 quarters · filed 2020-07-31 |
| 2020-03-31 | $5.34M 10-Q · filed 2020-05-05 | $109.82M derived: sum of 2 quarters · filed 2020-05-05 | $344.63M derived: sum of 3 quarters · filed 2020-05-05 | $572.80M derived: sum of 4 quarters · filed 2020-07-31 |
| 2019-12-31 | $104.48M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | $339.29M derived: sum of 2 quarters · filed 2020-02-28 | $567.46M derived: sum of 3 quarters · filed 2020-07-31 | $693.28M 10-K · filed 2020-02-28 |
| 2019-09-30 | $234.81M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $462.98M derived: sum of 2 quarters · filed 2020-07-31 | $588.80M 10-Q · filed 2019-10-31 | $618.97M derived: sum of 4 quarters · filed 2020-07-31 |
| 2019-06-30 | $228.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-31 | $354.00M 10-Q · filed 2020-07-31 | $384.16M derived: sum of 3 quarters · filed 2020-07-31 | $455.78M derived: sum of 4 quarters · filed 2020-07-31 |
| 2019-03-31 | $125.82M 10-Q · filed 2020-05-05 | $155.99M derived: sum of 2 quarters · filed 2020-05-05 | $227.61M derived: sum of 3 quarters · filed 2020-05-05 | $306.01M derived: sum of 4 quarters · filed 2020-05-05 |
| 2018-12-31 | $30.17M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | $101.79M derived: sum of 2 quarters · filed 2020-02-28 | $180.19M derived: sum of 3 quarters · filed 2020-02-28 | $180.19M 10-K · filed 2020-02-28 |
| 2018-09-30 | $71.62M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $150.02M derived: sum of 2 quarters · filed 2019-10-31 | $150.02M 10-Q · filed 2019-10-31 | $183.34M derived: sum of 4 quarters · filed 2020-02-28 |
| 2018-06-30 | $78.41M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $78.41M 10-Q · filed 2019-08-01 | $111.72M derived: sum of 3 quarters · filed 2020-02-28 | $256.42M derived: sum of 4 quarters · filed 2020-02-28 |
| 2018-03-31 | $0.00 10-Q · filed 2019-05-02 | $33.32M derived: sum of 2 quarters · filed 2020-02-28 | $178.02M derived: sum of 3 quarters · filed 2020-02-28 | $220.47M derived: sum of 4 quarters · filed 2020-02-28 |
| 2017-12-31 | $33.32M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | $178.02M derived: sum of 2 quarters · filed 2020-02-28 | $220.47M derived: sum of 3 quarters · filed 2020-02-28 | $390.24M 10-K · filed 2020-02-28 |
| 2017-09-30 | $144.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $187.15M derived: sum of 2 quarters · filed 2018-11-01 | $356.93M 10-Q · filed 2018-11-01 | $478.74M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-06-30 | $42.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $212.23M 10-Q · filed 2018-08-02 | $334.04M derived: sum of 3 quarters · filed 2019-02-28 | $376.47M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-03-31 | $169.78M 10-Q · filed 2018-05-03 | $291.59M derived: sum of 2 quarters · filed 2019-02-28 | $334.02M derived: sum of 3 quarters · filed 2019-02-28 | $431.46M derived: sum of 4 quarters · filed 2019-02-28 |
| 2016-12-31 | $121.81M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $164.25M derived: sum of 2 quarters · filed 2019-02-28 | $261.69M derived: sum of 3 quarters · filed 2019-02-28 | $405.61M 10-K · filed 2019-02-28 |
| 2016-09-30 | $42.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | $139.87M derived: sum of 2 quarters · filed 2017-11-02 | $283.80M 10-Q · filed 2017-11-02 | $423.95M derived: sum of 4 quarters · filed 2018-02-28 |
| 2016-06-30 | $97.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | $241.36M 10-Q · filed 2017-08-03 | $381.52M derived: sum of 3 quarters · filed 2018-02-28 | $493.06M derived: sum of 4 quarters · filed 2018-02-28 |
| 2016-03-31 | $143.93M 10-Q · filed 2017-05-04 | $284.08M derived: sum of 2 quarters · filed 2018-02-28 | $395.62M derived: sum of 3 quarters · filed 2018-02-28 | $477.51M derived: sum of 4 quarters · filed 2018-02-28 |
| 2015-12-31 | $140.15M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | $251.69M derived: sum of 2 quarters · filed 2018-02-28 | $333.58M derived: sum of 3 quarters · filed 2018-02-28 | $447.09M 10-K · filed 2018-02-28 |
| 2015-09-30 | $111.54M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-08 | $193.43M derived: sum of 2 quarters · filed 2016-11-08 | $306.94M 10-Q · filed 2016-11-08 | $393.48M derived: sum of 4 quarters · filed 2017-02-28 |
| 2015-06-30 | $81.89M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $195.40M 10-Q · filed 2016-08-04 | $281.94M derived: sum of 3 quarters · filed 2017-02-28 | $400.37M derived: sum of 4 quarters · filed 2017-02-28 |
| 2015-03-31 | $113.51M 10-Q · filed 2016-05-05 | $200.05M derived: sum of 2 quarters · filed 2017-02-28 | $318.48M derived: sum of 3 quarters · filed 2017-02-28 | $392.74M derived: sum of 4 quarters · filed 2017-02-28 |
| 2014-12-31 | $86.54M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $204.97M derived: sum of 2 quarters · filed 2017-02-28 | $279.23M derived: sum of 3 quarters · filed 2017-02-28 | $437.15M 10-K · filed 2017-02-28 |
| 2014-09-30 | $118.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-29 | $192.69M derived: sum of 2 quarters · filed 2015-10-29 | $350.61M 10-Q · filed 2015-10-29 | $440.54M derived: sum of 4 quarters · filed 2016-02-25 |
| 2014-06-30 | $74.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-30 | $232.18M 10-Q · filed 2015-07-30 | $322.11M derived: sum of 3 quarters · filed 2016-02-25 | $385.29M derived: sum of 4 quarters · filed 2016-02-25 |
| 2014-03-31 | $157.92M 10-Q · filed 2015-05-01 | $247.85M derived: sum of 2 quarters · filed 2016-02-25 | $311.03M derived: sum of 3 quarters · filed 2016-02-25 | $458.55M derived: sum of 4 quarters · filed 2016-02-25 |
| 2013-12-31 | $89.93M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | $153.11M derived: sum of 2 quarters · filed 2016-02-25 | $300.63M derived: sum of 3 quarters · filed 2016-02-25 | $303.92M 10-K · filed 2016-02-25 |
| 2013-09-30 | $63.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-30 | $210.71M derived: sum of 2 quarters · filed 2014-10-30 | $213.99M 10-Q · filed 2014-10-30 | $227.64M derived: sum of 4 quarters · filed 2015-02-26 |
| 2013-06-30 | $147.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-31 | $150.81M 10-Q · filed 2014-07-31 | $164.46M derived: sum of 3 quarters · filed 2015-02-26 | $174.46M derived: sum of 4 quarters · filed 2015-02-26 |
| 2013-03-31 | $3.28M 10-Q · filed 2014-05-01 | $16.93M derived: sum of 2 quarters · filed 2015-02-26 | $26.94M derived: sum of 3 quarters · filed 2015-02-26 | $42.60M derived: sum of 4 quarters · filed 2015-02-26 |
| 2012-12-31 | $13.65M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-26 | $23.65M derived: sum of 2 quarters · filed 2015-02-26 | $39.32M derived: sum of 3 quarters · filed 2015-02-26 | $67.51M 10-K · filed 2015-02-26 |
| 2012-09-30 | $10.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-01 | $25.67M derived: sum of 2 quarters · filed 2013-11-01 | $53.86M 10-Q · filed 2013-11-01 | $53.86M derived: sum of 4 quarters · filed 2014-02-28 |
| 2012-06-30 | $15.67M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-02 | $43.86M 10-Q · filed 2013-08-02 | $43.86M derived: sum of 3 quarters · filed 2014-02-28 | $43.86M derived: sum of 4 quarters · filed 2014-02-28 |
| 2012-03-31 | $28.19M 10-Q · filed 2013-05-03 | $28.19M derived: sum of 2 quarters · filed 2014-02-28 | $28.19M derived: sum of 3 quarters · filed 2014-02-28 | |
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | $0.00 derived: sum of 2 quarters · filed 2014-02-28 | $0.00 10-K · filed 2014-02-28 | |
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | $0.00 10-Q · filed 2012-11-09 | ||
| 2011-06-30 | $0.00 10-Q · filed 2012-08-02 | |||
| 2010-12-31 | $5.59M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-01 | $18.33M 10-K · filed 2013-03-01 | ||
| 2010-09-30 | $12.74M 10-Q · filed 2011-11-04 | |||
| 2009-12-31 | $42.92M 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |